Silo Pharma, Inc. (SILO)

Silo Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	3.9	4.75	3.91	3.52	11.37	9.84
Short-Term Investments	2.3	2.33	3.17	4.14	0	0.42
Cash & Short-Term Investments	6.21	7.08	7.08	7.67	11.37	10.26
Cash Growth	13.84%	0.00%	-7.63%	-32.58%	10.85%	808.83%
Other Receivables	-	-	-	-	0.07	-
Total Trade Receivables	-	-	-	-	0.07	-
Other Current Assets	0.6	0.31	0.03	0.02	0.14	0.15
Total Current Assets	6.8	7.39	7.11	7.68	11.57	10.4
Other Intangible Assets	0.21	0.22	0.24	-	-	-
Other Long-Term Assets	-	-	0.06	0.13	0.07	0.09
Total Assets	7.02	7.61	7.41	7.75	11.64	10.49

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	0.63	0.58	1.58	0.7	0.36	0.42
Unearned Revenue	0.07	0.07	0.07	0.07	0.07	0.07
Total Current Liabilities	0.7	0.65	1.66	0.78	0.44	0.49
Other Long-Term Liabilities	0.63	0.65	0.72	0.79	0.87	0.94
Total Long-Term Liabilities	0.63	0.65	0.72	0.79	0.87	0.94
Total Liabilities	1.34	1.3	2.38	1.57	1.3	1.43

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0	0	0	0	0	0
Treasury Stock	-	-	-	-0.47	-	-
Additional Paid-in Capital	26.81	25.79	20.3	17.53	17.51	12.32
Accumulated Other Comprehensive Income	0.01	0.01	0	-0.01	-	-
Retained Earnings	-21.14	-19.49	-15.26	-10.87	-7.17	-3.26
Shareholders' Equity	5.68	6.31	5.03	6.18	10.34	9.06
Total Liabilities & Equity	7.02	7.61	7.41	7.75	11.64	10.49

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Cash (Debt)	6.21	7.08	7.08	7.67	11.37	10.26
Net Cash Growth	13.84%	0.00%	-7.63%	-32.58%	10.85%	824.31%
Net Cash Per Share	8.72	12.67	28.86	37.33	74.67	80.20
Book Value	5.68	6.31	5.03	6.18	10.34	9.06
Book Value Per Share	7.98	11.28	20.52	30.08	67.91	70.86
Tangible Book Value	5.47	6.09	4.79	6.18	10.34	9.06
Tangible Book Value Per Share	7.68	10.89	19.53	30.08	67.91	70.86

SEC Filings: 10-K · 10-Q

Data Source: Fiscal.ai Last updated: May 13, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 24, 2026

Data Sources Report a data error